McKesson Cardiology Hemo Software Recall Due to Insufficient Maintenance Communication
McKesson Information Solutions LLC is recalling 625 McKesson Cardiology Hemo devices because communication regarding required annual maintenance testing was insufficient.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text describes an administrative failure (insufficient communication) regarding maintenance rather than a direct defect causing injury or death, fitting the criteria for a moderate severity voluntary precautionary recall.
Plain-English summary
McKesson Information Solutions LLC is recalling 625 units of the McKesson Cardiology Hemo device. This software is intended for complete physiological and hemodynamic monitoring, clinical data acquisition, medical image and data processing, and analytical assessment. The affected versions include 11.0HF5, 11.1, 11.1SP5, 11.1SP6, 11.1SP6HF1, 11.1SP6HF3, 12SP1, 12.1, 12.1HF1, 12.1HF2, 12.2, 12.2HF1, 12.2HF2, 12.2HF3, and 12.2HF4.
The recall was initiated because McKesson identified that its communication to customers regarding required maintenance tests was insufficient. The front-end parameter boxes of these devices must undergo annual maintenance testing to establish proper functioning and to identify in a timely manner whether a parameter box is out of calibration. While each unit has an attached sticker, the source text indicates the communication regarding these requirements was inadequate.
The devices were distributed worldwide, including in the United States (nationwide), Australia, Botswana, Canada, Germany, New Zealand, the Netherlands, Pakistan, Portugal, South Africa, Turkey, and the United Kingdom. The source text does not specify specific actions for consumers or healthcare providers beyond the context of the recall.
The recalled product
- Product
- McKesson Cardiology Hemo. McKesson Cardiology" Hemo is intended for complete physiological/hemodynamic monitoring, clinical data acquisition, medical image and data processing, and analytical assessment.
- Manufacturer
- Mckesson Information Solutions LLC
- Affected units
- 625
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- McKesson Cardiology TM Hemo versions: 11.0HF5
- 11.1
- 11.1SP5
- 11.1SP6
- 11.1SP6HF1
- 11.1SP6HF3
- 12SP1
- 12.1
- 12.1HF1
- 12.1HF2
- 12.2
- 12.2HF1
- 12.2HF2
- 12.2HF3
- 12.2HF4.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Mckesson Information Solutions LLC
See all →- HighMcKesson Cardiology Hemo Software Recall for Hemoglobin Calculation Error
FDA (Devices) · 2014-10-15
- HighMcKesson Recalls Horizon Medical Imaging PACS Software Due to Archive Errors
FDA (Devices) · 2014-02-19
- HighMcKesson Radiology 12.0 PACS Recall for Missing Contrast Allergy Data
FDA (Devices) · 2014-01-01
- HighMcKesson Horizon Medical Imaging System Recalled for Potential Image Loss
FDA (Devices) · 2013-10-09
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02